Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Patent
1995-12-19
1999-11-16
Chan, Christina Y.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
4241301, 4241331, 4241381, 4241411, 4241521, 4241721, 435 7021, 435330, 435326, 435332, 435346, 435452, 5303871, 5303873, 5303877, 5303882, 53038822, 5303888, 536 2353, A61K 39395, C07K 1628, C12N 1513, C12N 512
Patent
active
059852780
ABSTRACT:
The invention relates to a novel monoclonal antibody, a hybridoma cell line producing said antibody, DNA sequences coding for said antibody, and amino acid sequences. The monoclonal antibody, a preferred embodiment of which is named 17E6, has the following properties:
REFERENCES:
Osband et. al Immunol. Today 11:193-195 (1990).
Dermer Biotechnology 12:320 (1994).
Dillman J Clin. Oncol. 12:1497-1515 (1994).
Lehmann et al., Cancer Research 54:2102-2107 (1994).
Cheresh et al., J. Biol. Chem. 262:17703-17711 (1987).
Mitjans et al., J. Cell Sci. 108:2825-2838 (1995).
Marshall et al., J. Cell Sci. 108:1227-1238 (1995).
Adan Jaume
Goodman Simon
Hahn Diane
Mitjans Francesc
Piulats Jaume
Chan Christina Y.
Gambel Phillip
Merck Patent Gesellschaft mit beschrankter Haftung
LandOfFree
Anti-.alpha.V-integrin monoclonal antibody does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-.alpha.V-integrin monoclonal antibody, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-.alpha.V-integrin monoclonal antibody will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1320679